Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2026-01-03 @ 12:10 PM
Study NCT ID:
NCT04958967
Status:
WITHDRAWN
Last Update Posted:
2025-03-14
First Post:
2021-07-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase Ib Study of FURMONERTINIB in Patients with NSCLC Having Exon 20 Insertion Mutation
Sponsor:
Allist Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-05-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-05
First Submit QC Date:
None
Study First Post Date:
2021-07-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-12
Last Update Post Date:
2025-03-14
Last Update Post Date Type:
ACTUAL